(PAAS) Pan American Silver - Overview
Exchange: NYSE •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA6979001089
Stock: Silver, Gold, Zinc, Lead, Copper
Total Rating 61
Risk 35
Buy Signal -0.17
| Risk 5d forecast | |
|---|---|
| Volatility | 55.8% |
| Relative Tail Risk | -11.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.88 |
| Alpha | 149.30 |
| Character TTM | |
|---|---|
| Beta | 0.583 |
| Beta Downside | 1.723 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.50% |
| CAGR/Max DD | 1.57 |
EPS (Earnings per Share)
Revenue
Description: PAAS Pan American Silver March 03, 2026
Pan American Silver Corp. is a Vancouver-based mining entity focused on the exploration, development, and extraction of precious metals across the Americas. Operations span multiple jurisdictions, including Mexico, Peru, Canada, and Brazil, diversifying the geopolitical exposure often inherent to the extraction industry. The company organizes its portfolio into Silver and Gold segments, producing base metals such as zinc, lead, and copper as by-products of its primary refining processes.
The Silver segment encompasses assets like La Colorada and Juanicipio, while the Gold segment includes mines such as Jacobina and El Peñon. Investors seeking detailed valuation metrics can continue their research on ValueRay. Established in 1979, the company manages the full lifecycle of mineral assets, from initial discovery through final reclamation.
Headlines to watch out for
- Silver and gold prices dictate revenue and profitability
- Production costs impact mining margins
- Regulatory changes in Latin America affect operations
- Geopolitical instability in mining regions creates risk
- Exploration success replenishes mineral reserves
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 984.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 5.45 > 1.0 |
| NWC/Revenue: 37.85% < 20% (prev 36.66%; Δ 1.19% < -1%) |
| CFO/TA 0.14 > 3% & CFO 1.39b > Net Income 984.9m |
| Net Debt (-277.5m) to EBITDA (1.71b): -0.16 < 3 |
| Current Ratio: 2.69 > 1.5 & < 3 |
| Outstanding Shares: last quarter (422.1m) vs 12m ago 16.27% < -2% |
| Gross Margin: 38.56% > 18% (prev 0.19%; Δ 3.84k% > 0.5%) |
| Asset Turnover: 42.97% > 50% (prev 39.14%; Δ 3.84% > 0%) |
| Interest Coverage Ratio: 20.75 > 6 (EBITDA TTM 1.71b / Interest Expense TTM 58.0m) |
Altman Z'' 4.39
| A: 0.14 (Total Current Assets 2.19b - Total Current Liabilities 815.5m) / Total Assets 9.72b |
| B: -0.05 (Retained Earnings -512.1m / Total Assets 9.72b) |
| C: 0.14 (EBIT TTM 1.20b / Avg Total Assets 8.46b) |
| D: 2.55 (Book Value of Equity 6.98b / Total Liabilities 2.74b) |
| Altman-Z'' Score: 4.39 = AA |
Beneish M 1.00
| DSRI: 1.01 (Receivables 255.5m/195.8m, Revenue 3.64b/2.82b) |
| GMI: 0.50 (GM 38.56% / 19.46%) |
| AQI: 10.38 (AQ_t 0.23 / AQ_t-1 0.02) |
| SGI: 1.29 (Revenue 3.64b / 2.82b) |
| TATA: -0.04 (NI 984.9m - CFO 1.39b) / TA 9.72b) |
| Beneish M-Score: 2.27 (Cap -4..+1) = D |
What is the price of PAAS shares?
As of March 16, 2026, the stock is trading at USD 60.83 with a total of 6,503,539 shares traded.
Over the past week, the price has changed by -5.78%, over one month by -2.87%, over three months by +14.04% and over the past year by +122.52%.
Over the past week, the price has changed by -5.78%, over one month by -2.87%, over three months by +14.04% and over the past year by +122.52%.
Is PAAS a buy, sell or hold?
Pan American Silver has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy PAAS.
- StrongBuy: 3
- Buy: 3
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PAAS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 68.6 | 12.8% |
| Analysts Target Price | 68.6 | 12.8% |
PAAS Fundamental Data Overview March 13, 2026
P/E Trailing = 23.7617
P/E Forward = 13.7363
P/S = 7.0899
P/B = 3.6671
P/EG = 7.0214
Revenue TTM = 3.64b USD
EBIT TTM = 1.20b USD
EBITDA TTM = 1.71b USD
Long Term Debt = 709.0m USD (from longTermDebt, last quarter)
Short Term Debt = 57.9m USD (from shortTermDebt, last quarter)
Debt = 935.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -277.5m USD (from netDebt column, last quarter)
Enterprise Value = 25.28b USD (25.66b + Debt 935.3m - CCE 1.32b)
Interest Coverage Ratio = 20.75 (Ebit TTM 1.20b / Interest Expense TTM 58.0m)
EV/FCF = 23.59x (Enterprise Value 25.28b / FCF TTM 1.07b)
FCF Yield = 4.24% (FCF TTM 1.07b / Enterprise Value 25.28b)
FCF Margin = 29.46% (FCF TTM 1.07b / Revenue TTM 3.64b)
Net Margin = 27.08% (Net Income TTM 984.9m / Revenue TTM 3.64b)
Gross Margin = 38.56% ((Revenue TTM 3.64b - Cost of Revenue TTM 2.23b) / Revenue TTM)
Gross Margin QoQ = 47.21% (prev 36.63%)
Tobins Q-Ratio = 2.60 (Enterprise Value 25.28b / Total Assets 9.72b)
Interest Expense / Debt = 1.73% (Interest Expense 16.1m / Debt 935.3m)
Taxrate = 16.41% (90.1m / 548.9m)
NOPAT = 1.01b (EBIT 1.20b * (1 - 16.41%))
Current Ratio = 2.69 (Total Current Assets 2.19b / Total Current Liabilities 815.5m)
Debt / Equity = 0.13 (Debt 935.3m / totalStockholderEquity, last quarter 6.98b)
Debt / EBITDA = -0.16 (Net Debt -277.5m / EBITDA 1.71b)
Debt / FCF = -0.26 (Net Debt -277.5m / FCF TTM 1.07b)
Total Stockholder Equity = 5.84b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.64% (Net Income 984.9m / Total Assets 9.72b)
RoE = 16.85% (Net Income TTM 984.9m / Total Stockholder Equity 5.84b)
RoCE = 18.38% (EBIT 1.20b / Capital Employed (Equity 5.84b + L.T.Debt 709.0m))
RoIC = 15.35% (NOPAT 1.01b / Invested Capital 6.56b)
WACC = 7.84% (E(25.66b)/V(26.59b) * Re(8.07%) + D(935.3m)/V(26.59b) * Rd(1.73%) * (1-Tc(0.16)))
Discount Rate = 8.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 10.54%
[DCF] Terminal Value 78.77% ; FCFF base≈803.2m ; Y1≈807.0m ; Y5≈862.7m
[DCF] Fair Price = 37.77 (EV 15.65b - Net Debt -277.5m = Equity 15.93b / Shares 421.8m; r=7.84% [WACC]; 5y FCF grow 0.0% → 2.90% )
EPS Correlation: 79.39 | EPS CAGR: 70.53% | SUE: 1.98 | # QB: 1
Revenue Correlation: 92.15 | Revenue CAGR: 30.61% | SUE: 0.92 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.81 | Chg7d=-0.135 | Chg30d=-0.275 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=4.06 | Chg7d=+0.093 | Chg30d=+0.365 | Revisions Net=+6 | Growth EPS=+59.8% | Growth Revenue=+34.6%
EPS next Year (2027-12-31): EPS=4.54 | Chg7d=+0.220 | Chg30d=+0.834 | Revisions Net=+4 | Growth EPS=+11.8% | Growth Revenue=-2.8%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.9% (Discount Rate 8.1% - Earnings Yield 4.2%)
[Growth] Growth Spread = -3.9% (Analyst 0.0% - Implied 3.9%)
P/E Forward = 13.7363
P/S = 7.0899
P/B = 3.6671
P/EG = 7.0214
Revenue TTM = 3.64b USD
EBIT TTM = 1.20b USD
EBITDA TTM = 1.71b USD
Long Term Debt = 709.0m USD (from longTermDebt, last quarter)
Short Term Debt = 57.9m USD (from shortTermDebt, last quarter)
Debt = 935.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -277.5m USD (from netDebt column, last quarter)
Enterprise Value = 25.28b USD (25.66b + Debt 935.3m - CCE 1.32b)
Interest Coverage Ratio = 20.75 (Ebit TTM 1.20b / Interest Expense TTM 58.0m)
EV/FCF = 23.59x (Enterprise Value 25.28b / FCF TTM 1.07b)
FCF Yield = 4.24% (FCF TTM 1.07b / Enterprise Value 25.28b)
FCF Margin = 29.46% (FCF TTM 1.07b / Revenue TTM 3.64b)
Net Margin = 27.08% (Net Income TTM 984.9m / Revenue TTM 3.64b)
Gross Margin = 38.56% ((Revenue TTM 3.64b - Cost of Revenue TTM 2.23b) / Revenue TTM)
Gross Margin QoQ = 47.21% (prev 36.63%)
Tobins Q-Ratio = 2.60 (Enterprise Value 25.28b / Total Assets 9.72b)
Interest Expense / Debt = 1.73% (Interest Expense 16.1m / Debt 935.3m)
Taxrate = 16.41% (90.1m / 548.9m)
NOPAT = 1.01b (EBIT 1.20b * (1 - 16.41%))
Current Ratio = 2.69 (Total Current Assets 2.19b / Total Current Liabilities 815.5m)
Debt / Equity = 0.13 (Debt 935.3m / totalStockholderEquity, last quarter 6.98b)
Debt / EBITDA = -0.16 (Net Debt -277.5m / EBITDA 1.71b)
Debt / FCF = -0.26 (Net Debt -277.5m / FCF TTM 1.07b)
Total Stockholder Equity = 5.84b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.64% (Net Income 984.9m / Total Assets 9.72b)
RoE = 16.85% (Net Income TTM 984.9m / Total Stockholder Equity 5.84b)
RoCE = 18.38% (EBIT 1.20b / Capital Employed (Equity 5.84b + L.T.Debt 709.0m))
RoIC = 15.35% (NOPAT 1.01b / Invested Capital 6.56b)
WACC = 7.84% (E(25.66b)/V(26.59b) * Re(8.07%) + D(935.3m)/V(26.59b) * Rd(1.73%) * (1-Tc(0.16)))
Discount Rate = 8.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 10.54%
[DCF] Terminal Value 78.77% ; FCFF base≈803.2m ; Y1≈807.0m ; Y5≈862.7m
[DCF] Fair Price = 37.77 (EV 15.65b - Net Debt -277.5m = Equity 15.93b / Shares 421.8m; r=7.84% [WACC]; 5y FCF grow 0.0% → 2.90% )
EPS Correlation: 79.39 | EPS CAGR: 70.53% | SUE: 1.98 | # QB: 1
Revenue Correlation: 92.15 | Revenue CAGR: 30.61% | SUE: 0.92 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.81 | Chg7d=-0.135 | Chg30d=-0.275 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=4.06 | Chg7d=+0.093 | Chg30d=+0.365 | Revisions Net=+6 | Growth EPS=+59.8% | Growth Revenue=+34.6%
EPS next Year (2027-12-31): EPS=4.54 | Chg7d=+0.220 | Chg30d=+0.834 | Revisions Net=+4 | Growth EPS=+11.8% | Growth Revenue=-2.8%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.9% (Discount Rate 8.1% - Earnings Yield 4.2%)
[Growth] Growth Spread = -3.9% (Analyst 0.0% - Implied 3.9%)